Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Application of Phosphorylated Alpha Synuclein (p-syn) Skin Biopsy in Clinical Practice: Audit at an Academic Medical Center

Author:Wang, Cheng Chin   Robbins, Nathaniel   

Session Name:P8: Autonomic Disorders 1  

Topic:Autonomic Disorders  

Program Number:P8.004  

Author Institution:Dartmouth Health, Lebanon, NH  

Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis

Author:Cohen, Jeffrey   Hauser, Stephen   Cross, Anne   Winthrop, Kevin   Wiendl, Heinz   Nicholas, Jacqueline   Meuth, Sven   Giacomini, Paul   Sacca, Francesco   Zielman, Ronald   Das Gupta, Ayan   Hu, Xixi   Sullivan, Roseanne   DeLasHeras, Virginia   Kappos, Ludwig   

Session Name:P8: MS Therapeutics 2  

Topic:MS and Inflammatory Disease  

Program Number:P8.004  

Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH  UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA  Washington University School of Medicine, Saint Louis, MO, USA, Clayton, MO  Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, USA, Portland, OR  University of Muenster, Muenster, Germany, Muenster, Germany  OhioHealth Multiple Sclerosis Center, Columbus, OH, USA, Columbus, OH  Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, Duesseldorf, Germany  Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada  NSRO Department, University “Federico II” of Naples, Naples, Italy, Napoli, Italy  Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands  Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India  Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ  Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ  Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  

A Modern Artillery to put off the Electric Storm of the Brain– A case report of aborting seizure with brivaracetam 2-minute intravenous bolus in a patient with a compromised airway.